Brief: CNS Pharmaceuticals Inc Announces Investigator-Initiated Phase 1B/2 Trial To Be Conducted At The Pomeranian Medical University In Poland
12/01/2023 13:49
Jan 12 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* CNS PHARMACEUTICALS ANNOUNCES INVESTIGATOR-INITIATED PHASE
1B/2
TRIAL TO BE CONDUCTED AT THE POMERANIAN MEDICAL UNIVERSITY IN
POLAND
Source text for Eikon: ID:nPn1R2cLZa
Further company coverage: CNSP.O
((reuters.briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026